MX2009012345A - Derivados de 3,3-espiroindolinona. - Google Patents

Derivados de 3,3-espiroindolinona.

Info

Publication number
MX2009012345A
MX2009012345A MX2009012345A MX2009012345A MX2009012345A MX 2009012345 A MX2009012345 A MX 2009012345A MX 2009012345 A MX2009012345 A MX 2009012345A MX 2009012345 A MX2009012345 A MX 2009012345A MX 2009012345 A MX2009012345 A MX 2009012345A
Authority
MX
Mexico
Prior art keywords
spiroindolinone derivatives
spiroindolinone
derivatives
compounds
general formulas
Prior art date
Application number
MX2009012345A
Other languages
English (en)
Inventor
Jin-Jun Liu
Zhuming Zhang
Jefferson Wright Tilley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009012345A publication Critical patent/MX2009012345A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporcionan compuestos de las fórmulas generales (ver fórmulas (Ia) e (Ib)) en las que X, Y, R1, R2, R3, R4 y R5 tienen los significados definidos anteriormente. Estos compuestos presentan actividad anticancerosa.
MX2009012345A 2007-05-17 2008-05-06 Derivados de 3,3-espiroindolinona. MX2009012345A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93849407P 2007-05-17 2007-05-17
PCT/EP2008/055516 WO2008141917A1 (en) 2007-05-17 2008-05-06 3,3-spiroindolinone derivatives

Publications (1)

Publication Number Publication Date
MX2009012345A true MX2009012345A (es) 2009-12-01

Family

ID=39645551

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012345A MX2009012345A (es) 2007-05-17 2008-05-06 Derivados de 3,3-espiroindolinona.

Country Status (16)

Country Link
US (1) US7553833B2 (es)
EP (1) EP2158205B1 (es)
JP (1) JP2010527340A (es)
KR (1) KR101162518B1 (es)
CN (1) CN101679446B (es)
AR (1) AR066583A1 (es)
AT (1) ATE536355T1 (es)
AU (1) AU2008253154A1 (es)
BR (1) BRPI0811718A2 (es)
CA (1) CA2686675A1 (es)
ES (1) ES2377245T3 (es)
IL (1) IL201973A0 (es)
MX (1) MX2009012345A (es)
PE (1) PE20090279A1 (es)
TW (1) TW200906832A (es)
WO (1) WO2008141917A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638548B2 (en) * 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US7723372B2 (en) * 2008-03-19 2010-05-25 Hoffman-La Roche Inc. Spiroindolinone derivatives
US20100190814A1 (en) * 2009-01-26 2010-07-29 Li Chen Spiroindolinone derivative prodrugs
US7928233B2 (en) * 2009-02-10 2011-04-19 Hoffmann-La Roche Inc. Spiroindolinone pyridine derivatives
US8217051B2 (en) * 2009-02-17 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US8076482B2 (en) 2009-04-23 2011-12-13 Hoffmann-La Roche Inc. 3,3′-spiroindolinone derivatives
BR112012011317A2 (pt) 2009-11-12 2019-09-24 Univ Michigan Regents antagonistas espiro-oxindóis de mdm2
US8088815B2 (en) * 2009-12-02 2012-01-03 Hoffman-La Roche Inc. Spiroindolinone pyrrolidines
US8288431B2 (en) * 2010-02-17 2012-10-16 Hoffmann-La Roche Inc. Substituted spiroindolinones
US8217044B2 (en) 2010-04-28 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone pyrrolidines
JP2014500870A (ja) 2010-11-12 2014-01-16 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン スピロ−オキシインドールｍｄｍ２アンタゴニスト
WO2012121361A1 (ja) 2011-03-10 2012-09-13 第一三共株式会社 ジスピロピロリジン誘導体
JP2014513699A (ja) 2011-05-11 2014-06-05 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン スピロ−オキシインドールｍｄｍ２アンタゴニスト
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
ES2707305T3 (es) 2012-12-20 2019-04-03 Merck Sharp & Dohme Imidazopiridinas sustituidas como inhibidores de HDM2
CN103992334A (zh) * 2014-05-29 2014-08-20 中国人民解放军第二军医大学 吲哚酮螺四氢硫代吡喃类抗肿瘤衍生物及其制备方法
US10576064B2 (en) 2014-07-03 2020-03-03 Boehringer Ingelheim International Gmbh Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
KR102595395B1 (ko) 2015-02-20 2023-10-27 다이이찌 산쿄 가부시키가이샤 암의 병용 치료법
CN105541716B (zh) 2015-03-26 2024-02-23 Ａｇｃ株式会社 吡唑衍生物的制造方法
JP6823587B2 (ja) 2015-04-13 2021-02-03 第一三共株式会社 Ｍｄｍ２阻害剤とｂｔｋ阻害剤との併用治療法
EA036013B1 (ru) 2015-10-09 2020-09-14 Бёрингер Ингельхайм Интернациональ Гмбх Новые спиро[3h-индол-3,2'-пирролидин]-2(1h)-оновые соединения и производные в качестве ингибиторов mdm2-p53
CN113788818A (zh) 2016-04-06 2021-12-14 密执安大学评议会 Mdm2蛋白质降解剂
US10759808B2 (en) 2016-04-06 2020-09-01 The Regents Of The University Of Michigan Monofunctional intermediates for ligand-dependent target protein degradation
EP3458101B1 (en) 2016-05-20 2020-12-30 H. Hoffnabb-La Roche Ag Protac antibody conjugates and methods of use
CA3040840A1 (en) 2016-10-17 2018-04-26 Daiichi Sankyo Company, Limited Combined use of mdm2 inhibitor and dna methyltransferase inhibitor for cancer treatment
CN107337638A (zh) * 2017-08-14 2017-11-10 侯茜茜 一种吡啶甲酸类食品添加剂的高效合成方法
CA3112591A1 (en) 2018-10-08 2020-04-16 The Regents Of The University Of Michigan Small molecule mdm2 protein degraders
CN115776887A (zh) 2020-03-19 2023-03-10 凯麦拉医疗公司 Mdm2降解剂和其用途
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098212B (en) * 1981-05-12 1984-11-14 Ici Plc Process for preparing 1'-substituted-spiro(imidazolidine)-4,3'-indoline-2,2',5-triones
EP0947511A1 (en) 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
MY158766A (en) * 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
US20070213341A1 (en) * 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives

Also Published As

Publication number Publication date
ATE536355T1 (de) 2011-12-15
ES2377245T3 (es) 2012-03-23
AR066583A1 (es) 2009-09-02
TW200906832A (en) 2009-02-16
BRPI0811718A2 (pt) 2014-11-18
KR20090130312A (ko) 2009-12-22
CA2686675A1 (en) 2008-11-27
EP2158205B1 (en) 2011-12-07
CN101679446B (zh) 2012-06-27
PE20090279A1 (es) 2009-04-02
US7553833B2 (en) 2009-06-30
EP2158205A1 (en) 2010-03-03
AU2008253154A1 (en) 2008-11-27
JP2010527340A (ja) 2010-08-12
US20080287421A1 (en) 2008-11-20
IL201973A0 (en) 2010-06-16
KR101162518B1 (ko) 2012-07-09
WO2008141917A1 (en) 2008-11-27
CN101679446A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
MX2009004766A (es) Derivados de espiroindolinona.
IL197197A0 (en) Oxindole derivatives as anticancer agents
IL208025A0 (en) Spiroindolinone derivatives
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
EP1604665A4 (en) C-KIT KINASE HEMMER
MY160424A (en) Substituted pyrrolidine-2-carboxyamides.
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
IL193620A0 (en) Spiroindolinone derivatives
IL204437A (en) History of aryl cyclic profile and their use
TW200801003A (en) Novel compounds
TW200640926A (en) Pyrazolopyrimidines
MX2009009774A (es) Derivados de quinolina como fungicidas.
MY153921A (en) Aminopyrazole derivatives
TN2010000064A1 (en) Novel herbicides
IN2012DN02487A (es)
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
TN2010000061A1 (en) Tricyclic bridged cyclopentanedione derivatives as herbicides
TW200638930A (en) Acetylene derivatives
TW200738695A (en) Cis-4,5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors
PT1877367E (pt) Derivados do acetileno
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
TW200744612A (en) New combination
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
TN2010000094A1 (en) Novel herbicides

Legal Events

Date Code Title Description
FG Grant or registration